Diagnostic accuracy of Alzheimer's disease: a neuropathological study.
about
Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based studyCSF biomarkers for mild cognitive impairment.Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease.Methods to improve the detection of mild cognitive impairmentNeuropathologic substrates of ischemic vascular dementia.Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010.Evolution of the diagnostic criteria for degenerative and cognitive disorders.Post mortem sampling of the brain and other tissues in neurodegenerative disease.Cerebrospinal fluid protein biomarkers for Alzheimer's disease.CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatment.The brain injury biomarker VLP-1 is increased in the cerebrospinal fluid of Alzheimer disease patients.Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disordersBiomarkers for Alzheimer disease in cerebrospinal fluid, urine, and blood.Management of frontotemporal dementia: targeting symptom management in such a heterogeneous disease requires a wide range of therapeutic options.[18F]FDG-PET in patients with Alzheimer's disease: marker of disease spread.Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study.One-carbon metabolism and other biochemical correlates of cognitive impairment as visualized by principal component analysis.Frontotemporal dementia genetics.CSF biomarkers for Alzheimer's Disease: levels of beta-amyloid, tau, phosphorylated tau relate to clinical symptoms and survival.EEG Markers of Dementia with Lewy Bodies: A Multicenter Cohort Study.Local and systemic GM-CSF increase in Alzheimer's disease and vascular dementia.Recent clinical-pathologic research on the causes of dementia in late life: update from the Honolulu-Asia Aging Study.Alpha-synuclein pathology is highly dependent on the case selection.Phenotypic Heterogeneity in Dementia: A Challenge for Epidemiology and Biomarker Studies.
P2860
Q28366850-E38A4978-5FB9-4AC6-8EA4-168DD2089099Q30953185-291DC024-1489-4849-BBD2-C2C4A4DDBC13Q33666765-8F522211-0258-47E8-88F9-46F9A09DF26EQ33933152-46430A0E-1FE0-49C8-9336-46516CB23640Q34088144-ED016BA7-013B-43F6-A3ED-64A216519C72Q34262758-14752CDB-2904-45BB-96F7-10E6604955F9Q35708394-DC6E7D47-6DD5-4637-94A4-7C13063294B5Q35721063-8A63E215-FE1D-4E91-9F3F-F5A9BE52EBD2Q36045282-8BAB3D29-2CBE-405F-B756-AA3455E12D9CQ36252166-60BDC2C7-6745-440C-8188-51DE3CE37515Q37166782-3B99FAC3-AFB8-4130-BFE2-423CC4626233Q37249765-205BA90B-8006-434B-A425-107D0D546AEEQ37273675-51AC9FCE-117B-4A57-BC15-74F7A58914F3Q38391397-D613B492-0AF3-4BAD-8942-8B53EC5D6094Q40480799-171FB40E-1AFC-4442-B0D9-BEB99F7F0DDCQ42912092-EF0923E6-13A5-4331-B0FC-3913ADAEABC9Q43742214-0439B1C7-246E-4BBF-A9AE-A5877286442DQ46376402-B3055220-3E66-482E-AAB1-E74BC9A038C4Q46878198-9D518FDB-A1F6-4927-8E89-392561FA57F0Q48469027-DEC247E5-8390-4718-972C-4879A0DA1596Q48958948-A9F9DAD3-9633-431D-868A-22596E8CD971Q51923948-B2E86B04-1AF6-4564-965D-52A73346C350Q53243970-612ECCD9-BBC4-4276-AB8E-95C77CCFC7EDQ55512073-AA579112-0D8F-4C53-899D-B5DB15169BBB
P2860
Diagnostic accuracy of Alzheimer's disease: a neuropathological study.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Diagnostic accuracy of Alzheimer's disease: a neuropathological study.
@en
Diagnostic accuracy of Alzheimer's disease: a neuropathological study.
@nl
type
label
Diagnostic accuracy of Alzheimer's disease: a neuropathological study.
@en
Diagnostic accuracy of Alzheimer's disease: a neuropathological study.
@nl
prefLabel
Diagnostic accuracy of Alzheimer's disease: a neuropathological study.
@en
Diagnostic accuracy of Alzheimer's disease: a neuropathological study.
@nl
P2093
P2860
P356
P1476
Diagnostic accuracy of Alzheimer's disease: a neuropathological study.
@en
P2093
L Paljärvi
O Heinonen
P J Riekkinen
S Talasniemi
P2860
P2888
P304
P356
10.1007/S004010050412
P577
1996-01-01T00:00:00Z